CompletedNCT05098574
Oral contraceptives for premenstrual dysphoria in people with bipolarity
About this title
Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder
Read the official source — NCT05098574Medication studyAges 16–45Canada
Understand this study
Who was this study for?
This study was for people with bipolarity. Listed age limits: 16 years to 45 years. Other eligibility criteria applied.
- Listed locations
- HamiltonSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: February 3, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 17
- Sponsor
- St. Joseph's Healthcare Hamilton
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 16 Years to 45 Years
- Official registry ID
- NCT05098574
- Official title
Show the full official title
A Pilot, Randomized, Placebo-Controlled Trial Evaluating the Treatment of Premenstrual Dysphoric Disorder with Oral Contraceptives in Bipolar Disorder.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Hamilton
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is St. Joseph's Healthcare Hamilton.
Did this study involve medication?
Yes. The study involved medication, including Yaz and Placebo.
Who was this study for?
This study was for people with bipolarity. Listed age limits: 16 years to 45 years. Other eligibility criteria applied.
